Research peptide advertising rules: what the platforms allow
What Google and Meta policies say about unapproved and unsafe substances, why a research use only label is not a safe harbor, and what reviewers look at.
Short answer
Neither Google nor Meta publishes a rule that treats a "research use only" label as a safe harbor; both judge the product, the claims and the landing page, and both reserve the right to block substances they consider unapproved or unsafe. Google blocks unapproved substances regardless of any claims of legality, and Meta bans ads for unsafe substances as determined at its sole discretion, so peptide sellers carry real account risk on both platforms.
Last checked: against each platform's published policy pages. Not legal advice.
What we could and could not verify
We read the current policy pages from Google and Meta for this guide. None of them mention "research use only" or "research chemicals" by name, and none create an exception for them. What the pages do contain is broader language that a peptide product can fall under. This guide sticks to that language. It does not cover whether a given compound can legally be sold; that is a question for counsel.
- Unapproved substances. Google's policy blocks certain products "regardless of any claims of legality." It covers products that imply they are as effective as prescription drugs or controlled substances, products with names confusingly similar to an unapproved pharmaceutical or supplement, and products that have been the subject of government or regulatory action or warning. Google's list of examples is explicitly not exhaustive.
- Disease claims. Non-government-approved products marketed as safe or effective for preventing, curing or treating a disease are restricted on Google Ads and in Merchant Center.
- Enforcement. Unapproved substances violations come with a warning at least 7 days before suspension, and the policy is under Google's strike system, where repeat violations lead to holds and then suspension on the third strike. Trying to get around a disapproval by making variations of disapproved ads, domains or content, or by spreading violating ads across accounts, is circumventing systems, which suspends without warning.
Meta
- Unsafe substances. Meta's Drugs and Pharmaceuticals policy says ads cannot promote the sale or use of illicit or recreational drugs, or other unsafe substances, products or supplements, as determined by Meta at its sole discretion.
- Named examples. Meta's help page on the policy lists unsafe substances that include anabolic steroids, chitosan, comfrey, DHEA, ephedra and human growth hormones, and says the list is not limited to those.
- Prescription drugs. Anything promoted as a prescription drug needs LegitScript certification, Meta authorization, eligible countries and 18+ targeting.
- Landing pages count. Meta's Advertising Standards say review can include the ad's landing page, and the products in an ad must match those on the landing page.
Why a disclaimer does not change the review
A "research use only" or "not for human consumption" line sits next to whatever else the page says. If the ad, the images or the page talk about results in people, before and after outcomes, or comparisons to prescription drugs, that content is what reviewers read. Google's unreliable claims and unapproved substances language, and Meta's unsafe substances and health claim rules, apply to the content as a whole.
What we will not help with
Some sellers try to show reviewers a different page than buyers see, or route traffic through a clean-looking page that redirects. That is cloaking. Google defines it as showing different content to different people or to Google to hide things that might break its rules, and suspends accounts on detection without warning. Meta's spam policy prohibits presenting different off-platform content to its integrity systems than to users. We do not run it, and we do not recommend it.
If you sell peptides
- Assume both platforms can treat your product as unapproved or unsafe, and budget for the account risk.
- Keep human-use claims, outcome language and drug comparisons off ads and pages.
- Make sure the ad, the landing page and what you actually sell match.
- Get a legal opinion on what you can sell and say before you spend on ads.
This page is not legal advice.
Frequently asked questions
Does a research use only label make peptide ads compliant?
No published Google or Meta policy we reviewed treats that label as an exception. Both platforms review the product, the claims and the landing page as a whole.
Are research peptides on Google's unapproved substances list?
Google's list is explicitly non-exhaustive, and the policy also covers products implying they work like prescription drugs and products subject to regulatory action, so absence from the list is not approval.
Does Meta allow peptide ads?
Meta bans ads that promote unsafe substances, products or supplements as determined at its sole discretion, and its examples include human growth hormones and anabolic steroids. Expect peptide ads to face that review.
Is it safe to send ad reviewers to a different page than customers?
No. That is cloaking. Google suspends accounts for it on detection without warning, and Meta's spam policy prohibits it.
Sources
Every rule above comes from these pages, each read on November 9, 2026.
- Google Ads Policy Help: Unapproved substances
- Google Ads Policy Help: Unapproved pharmaceuticals and supplements
- Google Ads Policy Help: Strike-based system
- Google Merchant Center Help: Healthcare and medicines
- Google Ads Policy Help: Circumventing systems
- Meta Transparency Center: Drugs and Pharmaceuticals
- Meta Business Help Center: About Meta's Drugs and Pharmaceuticals advertising policy
- Meta Transparency Center: Introduction to the Advertising Standards
- Meta Transparency Center: Spam (Community Standards)